| 1 day | +0.40% |
| |||
| 1 week |
| -0.38% | |||
| 4 week |
| -3.11% | |||
| 3 month |
| -0.82% | |||
| YTD | +2.26% |
| |||
| 1 year | +3.81% |
| |||
| 3 years* |
| -1.60% | |||
| 5 years* | +3.49% |
| |||
| *annualized | |||||
| Best 3 month return | +32.34% | |
| Worst 3 month return | -30.28% |
| Return | Risk | Rating | |
| 3 years | Average | Low |
|
| 5 years | Above Average | Below Average |
|
| 10 years | - | - | - |
| Overall | Above Average | Below Average |
|
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
| Total assets | 1.27B | |
| Front load | 1.50% | |
| Deferred load | 1.80% | |
| Expense ratio | - | |
| Management fee | 1.50% | |
| Fund family | UBS SDIC Fund Mgmt Co.,Ltd |
| Cash | 15.31% | |
| Stocks | 81.53% | |
| Bonds | 5.03% | |
| Convertible | 0.17% | |
| Other | -2.05% |
| Initial | CN�1,000 | |
| Additional | CN�1,000 |
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 15.82 | 0.91 | 7.79 | - | |
| Beta* | 0.70 | 0.61 | 0.72 | - | |
| Mean annual return | 0.94 | 0.02 | 0.40 | - | |
| R-squared* | 77.52 | 55.28 | 82.86 | - | |
| Standard deviation | 17.87 | 16.21 | 23.91 | - | |
| Sharpe ratio | 0.46 | -0.17 | 0.08 | - | |
| * Against standard index | |||||
| Security | Net Assets | |
| Guizhou Yibai Pharmaceutical Co., Ltd. (600594) | 7.15% | |
| Ningbo Fuda Company Limited (600724) | 6.67% | |
| Guangdong CHJ Industry Co., Ltd. (002345) | 4.46% | |
| China Vanke Co., Ltd. (000002) | 4.42% | |
| Wuhan Humanwell Hi-tech Industry Company Limited (600079) | 4.13% | |
| The Export-Import Bank of China 2012 ser 20 | 3.87% | |
| China National Accord Medicines Corporation Ltd (000028) | 2.77% | |
| Fiyta Holdings Ltd. (000026) | 2.52% | |
| Ping An Insurance Group (601318) | 2.49% | |
| Topchoice Medical Investment Co., Inc. (600763) | 2.43% |